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Bis-benzamidines are an important family of minor groove DNA-binding agents. We present a one-step 
synthesis of aromatic aza-bisbenzamidines that allows the straightforward and versatile access to a large 
variety of these molecules. One of them, the fluorogenic azide-aza-bisbenzamidine 13, can be readily 
modified via click-chemistry with a variety of functionalities that can therefore be delivered to the 10 
vicinity of an A/T-rich DNA minor groove. This strategy therefore provides a simple means for triggering 
site selective DNA-promoted biochemical and physicochemical processes. 
Introduction 
A major research goal at the frontier between chemistry and 
biomedicine is the efficient and specific targeting of double 15 
stranded DNA with small molecules. Towards this end, a wide 
range of systems capable of binding to the DNA minor groove 
has been described over the years.1 In addition to well-known β-
hairpin polyamides that display very good DNA affinities and 
sequence specificities,2 bisbenzamidines, such as propamidine 20 
(1), pentamidine (3) of furamidine (5), represent simple but 
relevant alternatives for binding to A/T-rich sites,3 and have 
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Fig 1 Structures of propamidine (1), pentamidine (3), their aza versions 2 
and 4, and furamidine (5). 
Following our discovery that the aza-propamidine derivative 2 
displays strong fluorogenicity when binding to short A/T-rich 
sequences,5 we considered that a simple and versatile access to 30 
this type of molecules might provide new opportunities for 
discovering chemical, biophysical or biochemical processes 
triggered by specific DNA recognition events.6 In particular, we 
were called by the possibility of equipping these DNA binders 
with orthogonal handles to attach selected chemical cargoes, 35 
which could thus be delivered to the vicinity of specific DNA 
sites. It is surprising that, despite the extensive study of DNA 
binding processes, there are still very few precedents on the 
functional modification of the non-interacting face of synthetic 
DNA binders.7 Herein we describe a straightforward entry to a 40 
series of aza-bisbenzamidines featuring aromatic rings between 
the benzamidine units, including the phenylazido-derivative 13. 
This compound must display the azido group protruding out of 
the DNA surface when bound to the DNA minor groove, and 
therefore represents a valuable platform for delivering designed 45 
components to specific DNA locations.8 We describe the use of 
this derivative for the synthesis of three conjugates in which the 
appendages provide for obtaining different A/T specific, dsDNA-
promoted responses (Figure 2).  
 50 
Fig 2 Strategy for sequence-specific delivery of cargoes to the vicinity of 
specific DNA sites. 
Results and Discussion 
Synthesis of the aza-bisbenzamidines 
Given the commercial availability of the 4-amino benzene 55 
carboximidamide dihydrochloride (6), we designed a one-step 
approach to bisbenzamidines by reductive amination of suitable 
dialdehydes. Thus, treatment of 6 with isophthalaldehyde and 
NaBH3CN in H2O/MeCN for 30 min gave the desired 
bisbenzamidine 7 in a 77% yield (Figure 3). This method could 60 
be used with other commercially available dialdehydes, therefore 
providing a one-step entry to a number of aza-pentamidine 
derivatives, which were isolated as TFA salts. Furthermore, the 
1,4-benzylboronic acid 9 can be readily modified to introduce 
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other groups in place of the boronic acid, adding versatility to this 
approach. Thus, treatment of 9 with CuSO4 and sodium azide in 
MeOH provided the azide 13 in good yield (86%). 
 
Fig 3 One step synthesis of bis-4-aminobenzamidines 5 
DNA binding studies 
In contrast with classic bisbenzamidines, the above aza-
bisbenzamidines exhibit a strong push/pull dipolar electronic 
character, and thus display environment-sensitive properties, with 
enhanced fluorescence emission upon binding to the minor 10 
groove of their dsDNA target sites. Therefore, addition of 
successive aliquots of a dsDNA oligonucleotide containing a 
consensus AAATTT recognition site to a buffered solution of the 
aza-bisbenzamidine results in a progressive increase in the 
fluorescence emission upon irradiation at 329 nm (Figure 4).9 15 
These data show that the azido derivative 13 binds this DNA four 
times better than the parent meta-substituted phenyl derivative 7, 
and almost one order of magnitude better than the para-
substituted phenyl derivative 8 (Table 1).10 
 20 
Fig 4 Titrations of selected aromatic bisbenzamidines (0.5 µM in 20 mM 
Tris buffer, 100 mM NaCl, pH 7.5) with a target hairpin dsDNA 
oligonucleotide AAATTT. 7 (♦); 8 (◊); 9 (○); 10 (●) and 13 ( ). Binding 
curves represent the best fit to a 1:1 binding mode considering the 
contribution of the oligonucleotide to the emission. AAATTT: 5’–GGC 25 
AAATTT GAGTTTTTCTG AAATTT GCC–3’ (binding site in italics). 
In agreement with the selectivity exhibited by the parent aza-
pentamidine (4), these derivatives display a clear preference for 
dsDNA sites containing six consecutive A/T base pairs (AAATTT) 
over those with shorter A/T tracts of five (AATTT), or four 30 
(AATT) pairs,11 differences which are less pronounced in the case 
of the azido derivative 13. 
 







7 0.724 ± 0.09   1.2 ± 0.1  1.8 ± 0.1 
8  1.3 ± 0.2   1.5 ± 0.2  1.7 ± 0.1 
9  1.1 ± 0.1   1.5 ± 0.2  3.2 ± 0.5 
10 0.229 ± 0.063 0.334 ±0.004  1.0 ± 0.2 
11 0.563 ± 0.055  1.0 ± 0.1  1.9 ± 0.1 
12 0.246 ± 0.027 0.317 ± 0.043 0.782 ± 0.064 
13 0.206 ± 0.021 0.250 ± 0.049 0.362 ± 0.011 
4 0.393 ± 0.056 0.628 ± 0.077  1.1 ± 0.1  
KD values (µM) are the mean of three experiments. See the supporting 35 
information for oligo sequences and curve fitting analysis. 
 
As expected, breaking the A/T rich tract by introducing a single 
A → G mutation (site AAGTT) drastically reduces the stability of 
the complexes, except for the pyridine derivative 10, which is 40 
capable of binding to this site with much better affinity (KD ≈ 396 
nM) than the reference phenyl analog derivative 7 (KD ≈ 9.1 
μM).9 This result can be explained in terms of a hydrogen bond 
between the pyridine nitrogen and the NH2 group of the guanine, 
and represents one of the first observations of monomeric, high-45 
affinity binding of bisbenzamidine derivatives to sites other than 
pure A/T tracts.12 
 
Synthesis of conjugates 15a-c. 
Fig 5 Design and click-derivatization of the aza-bisbenzamidine 13 50 
Having the azide derivative 13 at hand, we were then challenged 
to demonstrate its potential as a handle for chemoselective 
ligations, and therefore we assembled three different conjugates 
using a copper-catalyzed 1,3-dipolar cycloaddition to suitable 
alkyne-containing fragments. Each conjugate was purposely 55 
designed to demonstrate the possibilities of this DNA binder as 
mediator in different photophysical, physicochemical or 
biochemical processes. Specifically, we coupled intermediate 13 
to a coumarine fluorophore (14a), an alkynyl-octaarginine 
fragment (14b), and a peptide derivative (14c) that features 28 60 
amino acids of the leucine rich region of the bZIP transcription 
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following standard procedures, by stirring the azide and the 
alkyne, in the presence of CuSO4 and sodium ascorbate.9,13 
 
Fig 6 Left: Fluorescence emission spectra of 13 (dashed lines) and 15a 
(solid lines) before, and after addition of a saturating concentration of the 5 
target hairpin oligonucleotide AAATTT. Spectra of 13 are scaled by a 
factor of 10 for clarity purposes. Bottom right: Incubation of 15a (5 µM) 
with Vero cells showing effective internalization after 30 min. a) bright 
field image; b) fluorescence emission of the same cells. 
The design of the bisbenzamidine-coumarine conjugate (15a) 10 
follows our previous observations on the generation of 
luminescence processes through a dsDNA-dependent 
intramolecular energy transfer between the benzamidine and 
other fluorophores.5,14 Gratifyingly, while the azido-
bisbenzamidine 13 shows a weak fluorescence emission at 386 15 
nm, and only a relatively small fluorescence increase in presence 
of an oligonucleotide containing the A/T-rich target sequence 
(AAATTT), conjugate 15a exhibits a remarkably large emission 
increase at a longer wavelength (≈ 470 nm) in the presence of this 
dsDNA (Figure 6). 20 
 
Fig 7 Fluorescence titrations of azide intermediate 13 and 15b (0.5 µM) 
in Tris buffer, 100 mM NaCl, pH 7.5 with a ds oligonucleotide featuring 
the AAATTT target site (see the supporting information). Proposed 
binding of 15b to the dsDNA, showing the (Arg)8 in the vicinity of the 25 
phosphates of the DNA backbone. Intensity is normalized to the 
saturation emission intensity of 15b 
In the case of the conjugate 15b, we reasoned that the presence of 
the octaarginine tail would significantly improve the dsDNA 
affinity of the system over an isolated bisbenzamidine. Indeed, 30 
fluorescence titrations revealed a KD ≈ 35 nM for its interaction 
with oligonucleotides containing a consensus A/T-rich binding 
site. These experiments, supported by EMSA assays (see the 
supporting information), also confirmed that the conjugate retains 
the specificity of the minor groove binder (Figure 7).15,16 35 
Remarkably, the click conjugation between the azide 13 and the 
alkyne 14b can also be carried out in the presence of the DNA. 
To our knowledge, this represents the first demonstration of an in 
situ click modification of a sequence-specific DNA binding 
agent, and sets the basis for future DNA-guided “gain of 40 
function” applications. 
 
Fig 8 Top: Schematic representation of the proposed interaction between 
hybrid 15c and cJun in a composite DNA site featuring the consensus 
recognition sites. Bottom: EMSA of hybrid 15c demonstrating binding to 45 
the composite site. Lanes 1-4, 50 nM ds-oligonucleotide ATF with 
increasing equimolar concentrations of cFos and cJun: 0, 250, 500 and 
1000 nM; lane 5: 50 nM ATFhs•A/T oligonucleotide; lanes 6-8, 50 nM 
ATFhs•A/T oligonucleotide with 300 nM of cJun and increasing 
concentrations of 15c: 0, 500, 1000 nM; lanes 9-11, 50 nM A/T 50 
oligonucleotide with increasing concentrations of cJun and 15c, 250, 500, 
1000 nM. Gel staining with SYBR-Gold. Oligo sequences (only one 
strand is shown): ATF: 5’−GACG ATGAcgTCAT GTTCG−3’; A/T: 
5’−GAC AAATTT GAGAGTACGCT−3’; ATFhs•A/T: 5’−GACG 
ATGAcgAAATTT GTTCG−3’. 55 
Finally, conjugate 15c was designed as an artificial mimetic of 
the DNA binding domain of cFos, a transcription factor which 
specifically binds the AP1 (5’–ATGAcTCAT–3’) or ATF/CREB 
(5’–ATGAcgTCAT–3’) DNA sites as a leucine zipper-mediated 
heterodimer with cJun.17 This heterodimer plays a fundamental 60 
role in regulating key genes involved in cell proliferation 
processes.18 As all members of the bZIP transcription factor 
family, monomeric cFos or cJun are unable to form stable DNA 
complexes, and high affinity DNA recognition requires their 
cooperative dimerization through a coiled-coil motive.19 65 
Conjugate 15c, designed on the basis of the crystal structures of 
both the cFos/cJun heterodimer and pentamidine bound to their 
respective DNA consensus sites,17,3b aims at stabilizing the 
cJun/DNA interaction but, in contrast with natural cFos, 15c 
delivers the cFos leucine-rich region from the DNA minor 70 
groove. Furthermore, the composite dimer cJun/15c targets a 
DNA sequence different from that of natural AP1 or ATF/CREB 
sites (Figure 8). 
Control EMSA experiments with cJun, cFos and a double 
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stranded-oligonucleotide containing the target ATF recognition 
site revealed the formation of the expected DNA complex of the 
cFos/cJun heterodimer (Figure 8, lanes 2-4, band a), together with 
smaller amounts of DNA complexes of homodimeric cJun/cJun 
and cFos/cFos complexes (Figure 8, lanes 2-4, bands b and c, 5 
respectively), in agreement with their relative stabilities.17 
Gratifyingly, while cJun cannot form stable complexes with the 
oligonucleotide ATFhs•A/T, featuring the consensus ATF half 
site and the bisbenzamidine preferred binding site (ATGA cg 
AAATTT), incubation of that mixture with increasing 10 
concentrations of conjugate 15c generates a new slow-migrating 
band (Lanes 6-8, band d), consistent with the formation of the 
expected ternary complex between the DNA, cJun and our 
artificial construct 15c. Moreover, the interaction is sequence-
selective, as oligonucleotides lacking the peptide target site (like 15 
A/T), or with a misplaced target sites (see the supporting 
information), fail to provide retarded bands.  
These results agree with the proposed interaction model, and 
confirm the potential of using minor groove binders as DNA 
anchors to deliver peptides with designed supramolecular 20 
properties into specific DNA sites. 
Conclusions 
In summary, we have developed a one step, versatile protocol for 
the synthesis of a series of new fluorogenic, sequence-selective 
DNA binding molecules. The strategy allows a simple access to a 25 
bisbenzamidine derivative (13), which delivers an azide moiety to 
the external face of the DNA minor groove. The azide represents 
an excellent handle for bioorthogonal conjugation to different 
alkyne partners, providing for a number of different DNA 
associated properties. Current efforts are focused on the extension 30 
of this supramolecular strategy to other functional systems, for 
non-covalent decoration of specific dsDNA sites, and for 
obtaining bioactive conjugates. 
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